PHIO PHARMACEUTICALS CORP. Debt Securities, Held-to-maturity, Current
PHIO PHARMACEUTICALS CORP. (PHIO) had Debt Securities, Held-to-maturity, Current of $2.00 million as of 2016-09-30, per its 10-Q filed 2016-11-10.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:HeldToMaturitySecuritiesCurrent · last filed 2017-03-30
- 2016-09-30: Debt Securities, Held-to-maturity, Current $2.00M.
- 2016-06-30: Debt Securities, Held-to-maturity, Current $2.00M.
- 2016-03-31: Debt Securities, Held-to-maturity, Current $3.50M.
- 2015-12-31: Debt Securities, Held-to-maturity, Current $5.50M.
| Period end | Debt Securities, Held-to-maturity, Current |
|---|---|
| 2016-09-30 | $2.00M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $2.00M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $3.50M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $5.50M 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |